General Papers
ARKIVOC 2016 (vi) 259-273
13
(d, J 8.0 Hz, 2H), 8.76 (ddd, J 7.2, 0.8, 1.2 Hz, 1H); C NMR (100 MHz, C6D6, TMS) δ 13.8
(CH3), 15.0 (CH3), 21.0 (CH3), 61.0 (CH2), 64.5 (CH2), 73.9 (CH), 100.1 (CH), 110.3 (CH), 115.1
(C), 118.2 (CH), 118.8 (CH), 126.3 (CH), 129.4 (CH), 129.9 (CH), 132.2 (C), 133.7 (C), 133.9
(C), 136.5 (C), 169.3 (C); MS (EI) 337 (M+, 11), 264 (100), 236 (35), 234 (29), 204 (21), 191 (17),
91 (11). Anal. Calcd. for C21H23NO3: C, 74.75; H, 6.87; N, 4.15. Found: C, 74.68; H, 6.58; N,
4.47 %.
1-[Ethoxy(4-butylphenyl)methyl]-2-ethoxycarbonylindolizine (4d). Pale yellow oil (152 mg,
1
40%); H NMR (400 MHz, C6D6, TMS) δ= 0.79 (t, J 7.2 Hz, 3H), 0.87 (dd, J 7.2, 7.2 Hz, 3H),
0.93 (dd, J 7.2, 7.2 Hz, 3H), 1.30 (tq, J 7.2, 7.2 Hz, 2H), 1.57 (tt, J 7.6, 7.2 Hz, 2H), 2.56 (t, J 7.6
Hz, 2H), 3.05 (dq, J 8.8, 7.2 Hz, 1H), 3.27 (dq, J 8.8, 7.2 Hz, 1H), 3.74 (dq, J 10.8, 7.2 Hz, 1H),
3.89 (dq, J 10.8, 7.2 Hz, 1H), 5.69 (s, 1H), 6.25 (ddd, J 6.4, 7.2, 1.2 Hz, 1H), 6.42 (ddd, J 8.8, 6.4,
0.8 Hz, 1H), 6.59 (s, 1H), 7.12 (ddd, J 8.8, 1.2, 1.2 Hz, 1H), 7.25 (d, J 8.0 Hz, 2H), 7.79 (d, J 8.0
Hz, 2H), 8.97 (ddd, J 7.2, 0.8, 1.2 Hz, 1H); 13C NMR (100 MHz, C6D6, TMS) δ= 13.8 (CH3), 14.0
(CH3), 15.0 (CH3), 22.6 (CH2), 33.9 (CH2), 35.6 (CH2), 61.1 (CH2), 64.5 (CH2), 73.9 (CH), 100.1
(CH), 110.3 (CH), 115.1 (C), 118.2 (CH), 118.8 (CH), 126.3 (CH), 128.9 (CH), 130.0 (CH), 132.2
(C), 133.9 (C), 141.6 (C), 151.7 (C), 169.3 (C); MS (EI) 379 (M+, 13), 306 (100), 278 (31), 263
(22), 234 (25), 204 (42), 192 (21), 161 (42), 107 (18), 91 (96), 77 (36), 69 (27), 57 (25).
1-[tert-Butoxy(phenyl)methyl]-2,3-bis(methoxycarbonyl)indolizine (5a). Colorless plates (304
mg, 77%); mp 118–119 °C; 1H NMR (90 MHz, CDCl3, TMS) δ= 1.22 (s, 9H), 3.87 (s, 3H), 3.95
(s, 3H), 5.94 (s, 1H), 6.80 (ddd, J 8.6, 6.7, 1.9 Hz, 1H), 6.98 (ddd, J 8.6, 8.8, 1.9 Hz, 1H), 7.1–7.6
(m, 5H), 7.73 (ddd, J 8.6, 1.9, 1.2 Hz, 1H), 9.35 (ddd, J 6.7, 1.9, 1.2 Hz, 1H); 13C NMR (23 MHz,
CDCl3, TMS) δ= 27.9 (CH3), 51.0 (CH3), 51.9 (CH3), 68.9 (CH), 74.9 (C), 109.7 (C), 113.8 (CH),
117.8 (C), 119.4 (CH), 121.7 (CH), 125.3 (C), 126.1 (CH), 126.4 (CH), 126.8 (CH), 127.8 (CH),
133.8 (C), 144.0 (C), 160.5 (C), 166.9 (C); IR (neat/cm-1) 1738, 1694; MS (EI) 395 (M+, 44), 338
(27), 322 (100), 306 (86), 262 (25), 230 (53). Anal. Calcd. for C23H25NO5: C, 69.86; H, 6.37; N,
3.54. Found: C, 69.77; H, 6.36; N, 3.54 %.
1-[Methoxy(phenyl)methyl]-2,3-bis(methoxycarbonyl)indolizine (5b). A solution of indolizine
5a (198 mg, 0.5 mmol) in methanol (10 mL) was heated under reflux for 5 hours. After evaporation,
5b (173 mg, 0.49 mmol, 98%) was obtained without any detectable by-product. Pale yellow plates;
mp 107–108 °C; 1H NMR (90 MHz, CDCl3, TMS) δ= 3.38 (s, 3H), 3.89 (s, 3H), 3.92 (s, 3H), 5.58
13
(s, 1H), 6.8–7.6 (m, 8H), 9.38 (br d, J 6.9 Hz, 1H); C NMR (23 MHz, CDCl3, TMS) δ= 51.1
(CH3), 52.1 (CH3), 56.6 (CH3), 78.1 (CH), 109.9 (C), 113.6 (C), 114.0 (CH), 118.7 (CH), 122.2
(CH), 126.2 (CH), 126.8 (CH), 127.0 (CH), 127.2 (C), 127.9 (CH), 133.8 (C), 141.2 (C), 160.4
(C), 166.6 (C); IR (neat/cm-1) 1742, 1704; MS (EI) 353 (M+, 35), 338 (27), 322 (100), 306 (38),
276 (26), 204 (17). Anal. Calcd. for C20H19NO5: C, 67.98; H, 5.42; N, 3.96. Found: C, 67.56; H,
5.32; N, 3.91 %.
Monitoring the oligomerization of indolizine 4a by 1H NMR
To a solution of indolizine 4a (3 mg, 10 μmol) in chloroform-d (0.5 mL), 1,1,2,2-tetrachloroethane
1
(8 mg) was added as an internal standard, and subjected to the measurements of H NMR at
several-minute intervals. The experiment was conducted in the air, and aluminium foil was used
Page 270
©ARKAT-USA, Inc.